As a leading 1H-3-Benzazepine-7,8-Diol, 6-Chloro-2,3,4,5-Tetrahydro-1-(4-Hydroxyphenyl)-, Methanesulfonate (1:1) (Salt) supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
1H-3-Benzazepine-7,8-Diol, 6-Chloro-2,3,4,5-Tetrahydro-1- (4-Hydroxyphenyl) -, Methanesulfonate (1:1) (Salt) What are the chemical synthesis steps?
To prepare 1H-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1- (4-hydroxyphenyl) -, methanesulfonate (1:1) (salt), the synthesis steps are as follows:
Start with 6-chloro-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol as the initial raw material. First react with appropriate protecting groups to protect specific hydroxyl groups from unprovoked reactions in subsequent reactions, resulting in impure products. In this step, mild reaction conditions and suitable protective reagents are required to ensure efficient reaction without damaging other groups.
Subsequently, the protected intermediate is reacted with 4-halogenated phenol in an alkaline environment and with the help of a catalyst. The phenolic hydroxyl group can be activated in the alkaline environment, and the catalyst accelerates the reaction process. The nucleophilic substitution reaction between the two successfully introduces 4-hydroxyphenyl at the first position of the benzazepine structure. This step requires fine adjustment of the alkali strength, catalyst dosage and reaction temperature to ensure the selectivity and yield of the reaction.
After the successful introduction of 4-hydroxyphenyl, remove the previously added protective group. According to the type of protecting group, the appropriate deprotection method is selected to obtain the key structure of the target product, 6-chloro-2,3,4,5-tetrahydro-1- (4-hydroxyphenyl) -1H-3-benzazepine-7,8-diol.
Finally, the obtained product is reacted with methanesulfonic acid in a 1:1 ratio in an appropriate solvent to form methanesulfonate (1:1) (salt). This salt-forming reaction requires controlling the reaction temperature and time to ensure that the purity and crystalline morphology of the product are up to standard. After the reaction, after crystallization, filtration, drying and other post-treatment processes, high purity 1H-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro- 1 - (4-hydroxyphenyl) -, methanesulfonate (1:1) (salt) is obtained. During the whole synthesis process, suitable analytical methods, such as thin-layer chromatography, nuclear magnetic resonance, etc. are required after each step of the reaction to monitor the reaction process and product purity, so as to adjust and optimize the reaction conditions in time.
What are the main physical properties of 1H-3-Benzazepine-7,8-Diol, 6-Chloro-2,3,4,5-Tetrahydro-1- (4-Hydroxyphenyl) -, Methanesulfonate (1:1) (Salt)?
This is 6-chloro-1- (4-hydroxyphenyl) -2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-glycol methanesulfonic acid (1:1) salt, its physical properties are particularly important, related to many application fields.
Looking at its properties, it is mostly white to quasi-white crystalline powder under normal conditions, which is conducive to preservation and subsequent processing, and is easily dispersed in many reaction systems, and can participate in the reaction efficiently.
Discussing solubility, this substance exhibits some solubility in water and some polar organic solvents. When dissolved in water, the molecular structure contains polar groups, which can interact with water molecules to form hydrogen bonds, etc., and then dissolve in the aqueous phase. This property is of great significance in the field of pharmaceutical preparations, etc., and can ensure its effective dispersion and absorption in organisms.
Melting point is also one of the key physical properties, and its melting point is in a specific range. This characteristic can be used for identification and purity detection. When the purity of the substance is high, the melting point range is relatively narrow and close to the theoretical value; if it contains impurities, the melting point may be offset or the melting range may be widened, according to which the quality of the substance can be judged.
In addition, its stability cannot be ignored. Under normal storage conditions, it can maintain relatively stable structure and properties in a dry and cool place. However, if exposed to high temperature, high humidity or strong light, the molecular structure may change, resulting in changes in properties, so the storage and transportation process needs to be strictly controlled environmental conditions.
The physical properties of this compound are interrelated and play a decisive role in its application in medicine, chemical industry and other fields. Practitioners need to consider it carefully in order to make good use of its properties and achieve the desired purpose.
What are the applications of 1H-3-Benzazepine-7,8-Diol, 6-Chloro-2,3,4,5-Tetrahydro-1- (4-Hydroxyphenyl) -, Methanesulfonate (1:1) (Salt) in the field of medicine?
This is 6-chloro-1- (4-hydroxyphenyl) -2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-glycol methanesulfonic acid (1:1) salt, which is widely used in the field of medicine. First, it is often used in the treatment of nervous system diseases. This compound may regulate the release and transmission of neurotransmitters, and has potential efficacy in psychiatric diseases such as anxiety and depression. Because it can act on specific nerve receptors, it helps balance the activity of neural circuits and relieve related symptoms. Second, it also plays a role in the prevention and treatment of cardiovascular diseases. It may regulate the physiological functions of the cardiovascular system, such as affecting the contraction and relaxation of vascular smooth muscles, which in turn regulates blood pressure, and may have certain value in the treatment of cardiovascular diseases such as hypertension. Third, for some neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, the compound may play a neuroprotective effect by protecting nerve cells, inhibiting neuroinflammation and other mechanisms, delaying the progression of the disease. In addition, in the field of drug development, it is often used as a lead compound to provide a key template for the creation of new drugs. Scientists can modify and optimize its structure to improve efficacy, reduce side effects, and promote the continuous progress of medical science.
What is the market outlook for 1H-3-Benzazepine-7,8-Diol, 6-Chloro-2,3,4,5-Tetrahydro-1- (4-Hydroxyphenyl) -, Methanesulfonate (1:1) (Salt)?
Guanfu 1H-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1 - (4-hydroxyphenyl) -, methanesulfonate (1:1) (salt). In today's world, the field of medicine is booming, and all kinds of new drug research and development have sprung up. This compound may have potential value in the process of pharmaceutical research and development due to its unique chemical structure. From the perspective of its structure, the combination of benzazepine, hydroxyphenyl and other groups may endow it with specific biological activities.
In the field of medicinal chemistry, researchers often search for compounds with novel structures, hoping that they can have an effect on specific disease targets. The unique structure of this compound may attract the attention of pharmaceutical developers and become a potential lead compound for the creation of new drugs. If its pharmacological activity can be deeply studied, it may be possible to develop innovative drugs for specific diseases.
However, looking at its market prospects, there are also challenges. The road to new drug development is difficult, time-consuming and expensive. From compounds to drugs that are finally approved for marketing, many rigorous trials are required, including preclinical studies, clinical trials, etc. During this period, many considerations such as drug safety and effectiveness need to be addressed. If this compound wants to make its mark in the market, it must demonstrate excellent performance in these key links.
And today's pharmaceutical market is fiercely competitive, and many pharmaceutical companies are committed to the development of new drugs. It is not easy for this compound to stand out among many potential drug candidates. However, if it can overcome many difficulties with its unique activity and good drug-ready properties, it will surely gain a place in the market, bring new vitality and hope to the pharmaceutical industry, and benefit many patients.
What are the key quality control points during the production of 1H-3-Benzazepine-7,8-Diol, 6-Chloro-2,3,4,5-Tetrahydro-1- (4-Hydroxyphenyl) -, Methanesulfonate (1:1) (Salt)?
In the production process of 1H-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro- 1 - (4-hydroxyphenyl) -, mesylate (1:1) (salt), there are many key quality control points, which are described as follows:
For starting materials, the purity and quality of the raw materials are of paramount importance. Among them, 6-chloro-2,3,4,5-tetrahydro-1- (4-hydroxyphenyl) -1H-3-benzazepine-7,8-diol and methanesulfonic acid, the impurity content needs to be strictly controlled. Too many impurities, or the increase of reaction by-products, affect the purity and yield of the product.
The reaction conditions should not be underestimated. For temperature, precise regulation is required. If the temperature is too high, the reaction may be too violent, triggering side reactions; if the temperature is too low, the reaction rate will be slow, the time-consuming will be too long, and the product configuration will be affected. The same is true for pressure, and the appropriate pressure can ensure the smooth progress of the reaction. In addition, the reaction time also needs to be strictly controlled. If the time is too short, the reaction will not be fully functional; if the time is too long, it may cause the product to decompose.
Monitoring of the reaction process is very important. With the help of high performance liquid chromatography (HPLC), mass spectrometry (MS) and other analytical methods, the reaction process can be monitored in real time to understand the consumption of raw materials and product formation, so as to adjust the reaction parameters in time.
Separation and purification steps are the key to obtaining pure products. Extraction, crystallization, column chromatography and other methods need to be used reasonably. During extraction, the choice of extractant is related to the extraction efficiency of the product and the removal effect of impurities; during the crystallization process, crystallization conditions such as temperature and solvent ratio affect the crystal purity and crystal form; during column chromatography, the choice of filler and the ratio of eluent determine the separation effect of the product.
The quality detection of the product should not be ignored. In addition to the detection of purity, it is necessary to determine its physical properties such as melting point and optical rotation, and compare it with the standard. Infrared spectroscopy (IR), nuclear magnetic resonance (NMR) and other means are used to confirm that the structure of the product is correct. The moisture content also needs to be strictly controlled. Excessive moisture may affect the stability and storage life of the product.